RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Fund+
F

Fund+ portfolio

Fund+ has 2 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months. Its most recent investment on record is Ona Therapeutics's $86.6M Series B+ round in June 2026, alongside Mérieux Equity Partners, Columbus Venture Partners, Ysios Capital and 6 others. By category, its portfolio leans toward Health and bio (2) and Logistics and mobility (1). It has co-invested with HTGF, Seventure Partners and OCCIDENT, most often HTGF (3 rounds).

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 2.
Capital in their rounds: $681.52M.
Latest deal: Ona Therapeutics · Jun 4, 2026.

What Fund+ invests in

Fund+ recent investments

How Fund+ invests

StageDealsCapital in rounds
Series B+ 4 80%$647.6M
Series A 1 20%$33.92M
YearDealsCapital in rounds
2020 1 20%$33.92M
2022 1 20%$63M
2024 1 20%$138M
2025 1 20%$360M
2026 1 20%$86.6M

Share is of the 5 rounds on Recent Funding that name Fund+. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Fund+ portfolio companies

CompanyRound with Fund+Total raisedLatest raise
OOna Therapeutics
Health and bio
Series B+ · $86.6M$207.12MOct 5, 2026
Series B+
TTubulis
Health and bio
Series B+ · $360M$573MOct 16, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Fund+, which is a subset of its real portfolio. API: /api/v1/investors/fund (get a free API key). More: the most active VC firms and new venture capital funds.